These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 3871244)
1. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents. Fuller RW; Steranka LR Life Sci; 1985 Jan; 36(3):243-7. PubMed ID: 3871244 [TBL] [Abstract][Full Text] [Related]
2. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW; Robertson DW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775 [TBL] [Abstract][Full Text] [Related]
4. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853 [TBL] [Abstract][Full Text] [Related]
6. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW; Hemrick-Luecke SK; Perry KW J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609 [TBL] [Abstract][Full Text] [Related]
7. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. Fuller RW; Hemrick-Luecke SK Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601 [TBL] [Abstract][Full Text] [Related]
8. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice. Perez V; Unzeta M Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice. Fuller RW; Hemrick-Luecke SK Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Sundström E; Jonsson G Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083 [TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151 [TBL] [Abstract][Full Text] [Related]
12. Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW; Hemrick-Luecke SK Life Sci; 1985 Sep; 37(12):1089-96. PubMed ID: 3875779 [TBL] [Abstract][Full Text] [Related]
13. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP. Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028 [TBL] [Abstract][Full Text] [Related]
15. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart. Fuller RW; Hemrick-Luecke SK; Robertson DW Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433 [TBL] [Abstract][Full Text] [Related]
17. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity. Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638 [TBL] [Abstract][Full Text] [Related]
19. MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species. Jossan SS; Sakurai E; Oreland L Pharmacol Toxicol; 1989 Mar; 64(3):314-8. PubMed ID: 2786198 [TBL] [Abstract][Full Text] [Related]
20. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies. Del Zompo M; Piccardi MP; Bernardi F; Bonuccelli U; Corsini GU Brain Res; 1986 Jul; 378(2):320-4. PubMed ID: 3089539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]